Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01247987 · ClinicalTrials.gov registry record · NA

Comparison of Transfers of Thawed Blastocysts Versus Blastocysts Derived From Thawed Bipronuclear Oocytes

A NA study of Infertility, sponsored by Bruce Shapiro M.D..

Completed
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT01247987 is a NA study of Infertility that has completed, run by Bruce Shapiro M.D.. The registered enrollment target is 140 participants, below the 7,588-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01247987, a NA study of Infertility, has completed, sponsored by Bruce Shapiro M.D..

COMPLETED
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if cryopreservation at the blastocyst stage followed by embryo thaw and transfer is as effective as cryopreservation of bipronuclear oocytes followed by post-thaw extended culture (PTEC), and blastocyst transfer. Effectiveness will be measured by the rate of ongoing pregnancy at 10 weeks gestation.

Conditions Studied

Interventions

  • PROCEDURE Blastocyst cryopreservation
  • PROCEDURE Bipronuclear oocyte cryopreservation

Study Locations (1)

Nevada

  • Fertility Center of Las Vegas - Las Vegas

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2010-12
Est. Completion 2015-04
Phase NA

Sponsor

Bruce Shapiro M.D.

3 total trials

What the Registry Record Tells You About NCT01247987

The ClinicalTrials.gov registry entry for NCT01247987 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,588-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The listed sponsor is Bruce Shapiro M.D., which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which Blastocyst cryopreservation is the first listed.

NCT01247987 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.

Frequently Asked Questions

What is clinical trial NCT01247987 about?

NCT01247987 is a clinical study titled "Comparison of Transfers of Thawed Blastocysts Versus Blastocysts Derived From Thawed Bipronuclear Oocytes". The purpose of this study is to determine if cryopreservation at the blastocyst stage followed by embryo thaw and transfer is as effective as cryopreservation of bipronuclear oocytes followed by post-thaw extended culture (PTEC), and blastocyst transfer. Effectiveness will be measured by the rate of...

What is the current status of trial NCT01247987?

This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2010-12. Estimated completion is 2015-04.

What conditions does trial NCT01247987 study?

This clinical trial studies the following conditions: Infertility.

What interventions are being tested in trial NCT01247987?

The interventions under investigation include: Blastocyst cryopreservation (PROCEDURE), Bipronuclear oocyte cryopreservation (PROCEDURE).

Who is sponsoring clinical trial NCT01247987?

This trial is sponsored by Bruce Shapiro M.D., which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01247987 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.